Abstract
A series of nine patients with chronic granulomatous disease have been maintained on continuous nafcillin therapy for a period adequate to allow preliminary evaluation. Clinically significant hepatic sepsis has not occurred since initiation of this program. The effect on extra-hepatic sepsis is not yet clearly established.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
